Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer.
作者信息
Blazer Kathleen R, Slavin Thomas, Weitzel Jeffrey N
机构信息
Division of Clinical Cancer Genetics, City of Hope, Duarte, California.
出版信息
JAMA Oncol. 2016 Jun 1;2(6):723-4. doi: 10.1001/jamaoncol.2015.5975.
Abstract
摘要
相似文献
1
Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer.扩大遗传性乳腺癌精准管理工具——遗传癌症风险评估的应用范围
JAMA Oncol. 2016 Jun 1;2(6):723-4. doi: 10.1001/jamaoncol.2015.5975.
2
Precision medicine meets public health: population screening for BRCA1 and BRCA2.精准医学与公共卫生相遇：BRCA1和BRCA2的人群筛查
J Natl Cancer Inst. 2014 Dec 30;107(1):420. doi: 10.1093/jnci/dju420. Print 2015 Jan.
3
Treating the genetic make-up of breast cancer: a new fashion?治疗乳腺癌的基因组成：一种新潮流？
Expert Rev Anticancer Ther. 2007 Aug;7(8):1065-7. doi: 10.1586/14737140.7.8.1065.
4
BRCA1 and BRCA2 Testing Among Young Breast Cancer Survivors.年轻乳腺癌幸存者中的BRCA1和BRCA2检测
JAMA Oncol. 2016 May 1;2(5):688-9. doi: 10.1001/jamaoncol.2016.0976.
5
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families.BRCA基因突变阳性家族中BRCA基因突变阴性女性的乳腺癌风险。
Lancet Oncol. 2007 Dec;8(12):1042-1043. doi: 10.1016/S1470-2045(07)70348-0.
6
Genetic testing in women with breast cancer: implications for treatment.乳腺癌女性的基因检测：对治疗的影响
Expert Rev Anticancer Ther. 2017 Nov;17(11):991-1002. doi: 10.1080/14737140.2017.1374175. Epub 2017 Sep 8.
7
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.BRCA1 和 BRCA2 基因突变携带者行输卵管卵巢切除术后的乳腺癌筛查。
Breast Cancer Res Treat. 2011 Aug;129(1):157-64. doi: 10.1007/s10549-011-1423-4. Epub 2011 Mar 4.
8
BRCA to the future: towards best testing practice in the era of personalised healthcare.BRCA走向未来：迈向个性化医疗时代的最佳检测实践。
Eur J Hum Genet. 2016 Sep;24 Suppl 1(Suppl 1):S1-2. doi: 10.1038/ejhg.2016.92.
9
Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.BRCA1和BRCA2突变携带者的乳腺钼靶筛查与乳腺癌风险：一项病例对照研究。
Lancet Oncol. 2006 May;7(5):402-6. doi: 10.1016/S1470-2045(06)70624-6.
10
Genetic Testing After Previous BRCA Testing: A Case Study.先前BRCA检测后的基因检测：一个案例研究。
Clin J Oncol Nurs. 2016 Dec 1;20(6):660-663. doi: 10.1188/16.CJON.660-663.
引用本文的文献
1
Understanding Genetic Screening: Harnessing Health Information to Prevent Disease Risks.了解基因筛查：利用健康信息预防疾病风险。
Int J Med Sci. 2025 Jan 21;22(4):903-919. doi: 10.7150/ijms.101219. eCollection 2025.
2
Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment.横断面临床癌症基因组学实践社区调查分析了提供者对使用已故家庭成员组织来指导活的家庭成员遗传癌症风险评估的态度和信念。
J Genet Couns. 2022 Oct;31(5):1164-1172. doi: 10.1002/jgc4.1587. Epub 2022 May 26.
3
Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review.选择性雌激素受体调节剂在绝经前女性乳腺癌预防中的应用综述
Transl Cancer Res. 2020 Jul;9(7):4444-4456. doi: 10.21037/tcr-19-1956.
4
Genetic Counseling Clinic at AIIMS (New Delhi).全印医学科学研究所（新德里）遗传咨询诊所
Indian J Surg Oncol. 2021 Apr;12(Suppl 1):30-33. doi: 10.1007/s13193-020-01054-1. Epub 2020 Apr 4.
5
Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.发现乳腺癌风险基因，并建立基于雌激素代谢调控的预测模型。
BMC Cancer. 2021 Feb 25;21(1):194. doi: 10.1186/s12885-021-07896-4.
6
Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women: A prospective case-control study.雌激素代谢基因多态性与中国女性乳腺癌发生的关联：一项前瞻性病例对照研究。
Medicine (Baltimore). 2018 Nov;97(47):e13337. doi: 10.1097/MD.0000000000013337.
7
Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population.中国人群遗传性高危样本中BRCA1/2基因突变特征及其与乳腺癌临床病理特征的关系
Oncol Lett. 2018 Mar;15(3):3068-3074. doi: 10.3892/ol.2017.7717. Epub 2017 Dec 29.
8
Decision making for breast cancer prevention among women at elevated risk.乳腺癌高危女性的预防决策
Breast Cancer Res. 2017 Mar 24;19(1):34. doi: 10.1186/s13058-017-0826-5.
本文引用的文献
1
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.BRCA1 和 BRCA2 基因突变检测在年轻乳腺癌女性中的应用。
JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.
2
Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings.癌症风险的下一代检测：社区医疗环境中早期采用者的认知、体验和需求
Genet Test Mol Biomarkers. 2015 Dec;19(12):657-65. doi: 10.1089/gtmb.2015.0061. Epub 2015 Nov 5.
3
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.美国临床肿瘤学会政策声明更新：癌症易感性的遗传和基因组检测。
J Clin Oncol. 2015 Nov 1;33(31):3660-7. doi: 10.1200/JCO.2015.63.0996. Epub 2015 Aug 31.
4
Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?全人群种系BRCA1和BRCA2突变筛查：好事过头了？
J Clin Oncol. 2015 Oct 1;33(28):3092-5. doi: 10.1200/JCO.2015.60.8596. Epub 2015 Aug 17.
5
Gene-panel sequencing and the prediction of breast-cancer risk.基因panel测序与乳腺癌风险预测
N Engl J Med. 2015 Jun 4;372(23):2243-57. doi: 10.1056/NEJMsr1501341. Epub 2015 May 27.
6
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.安吉丽娜·朱莉效应：名人的高知名度如何对癌症相关服务的提供产生重大影响。
Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
7
Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011.1998 年至 2011 年加利福尼亚州乳腺癌患者行双侧乳房切除术与其他手术治疗方法的应用及死亡率比较。
JAMA. 2014 Sep 3;312(9):902-14. doi: 10.1001/jama.2014.10707.
8
Preoperative genetic testing affects surgical decision making in breast cancer patients.术前基因检测影响乳腺癌患者的手术决策。
Gynecol Oncol. 2014 Aug;134(2):326-30. doi: 10.1016/j.ygyno.2014.05.028. Epub 2014 Jun 5.
9
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.遗传学、基因组学与癌症风险评估：个性化医疗时代的现状与未来方向
CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19.
10
Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals.未受影响的 BRCA 和错配修复（MMR）突变阳性个体的调查。
Fam Cancer. 2009;8(4):363-9. doi: 10.1007/s10689-009-9248-6. Epub 2009 May 24.
Zotero 插件